APO Research
Talk to an analyst

APO RESEARCH · REPORT

Anti-HMGB1 Antibody

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Anti-HMGB1 Antibody Industry Growth and Trends Forecast to 2032

28 December 2025109 pages

Choose your research edition.

Industry ResearchAnti-HMGB1 Antibody Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Anti-HMGB1 Antibody Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Anti-HMGB1 Antibody Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anti-HMGB1 Antibody Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Anti-HMGB1 Antibody Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Anti-HMGB1 Antibody market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Anti-HMGB1 Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Anti-HMGB1 Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Anti-HMGB1 Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Anti-HMGB1 Antibody include Abcam, Arigo Biolaboratories, Atlas Antibodies, BioLegend, BosterBio, Chondrex, Genetex, Leadgene Biomedical and Raybiotech, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Anti-HMGB1 Antibody market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Anti-HMGB1 Antibody market size, estimates, and forecasts are presented in terms of sales volume (Kg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Anti-HMGB1 Antibody market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Anti-HMGB1 Antibody.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Anti-HMGB1 Antibody market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Anti-HMGB1 Antibody Market by Company

Abcam

Arigo Biolaboratories

Atlas Antibodies

BioLegend

BosterBio

Chondrex

Genetex

Leadgene Biomedical

Raybiotech

St John's Laboratory

Thermo Fisher Scientific

Merck

Sino Biological

Anti-HMGB1 Antibody Segment by Type

Rabbit Anti-HMGB1 Antibody

Mouse Anti-HMGB1 Antibody

Anti-HMGB1 Antibody Segment by Application

ELISA

Immunofluorescence

Western Blot

Others

Anti-HMGB1 Antibody Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-HMGB1 Antibody market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anti-HMGB1 Antibody and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-HMGB1 Antibody.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Anti-HMGB1 Antibody manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Anti-HMGB1 Antibody in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Rabbit Anti-HMGB1 Antibody Table 2. Major Company of Mouse Anti-HMGB1 Antibody Table 3. Global Anti-HMGB1 Antibody Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Anti-HMGB1 Antibody Sales by Type (2021-2026) & (Kg) Table 5. Global Anti-HMGB1 Antibody Sales Market Share in Volume by Type (2021-2026) Table 6. Global Anti-HMGB1 Antibody Sales by Type (2021-2026) & (US$ Million) Table 7. Global Anti-HMGB1 Antibody Sales Market Share in Value by Type (2021-2026) Table 8. Global Anti-HMGB1 Antibody Price by Type (2021-2026) & (US$/G) Table 9. Global Anti-HMGB1 Antibody Sales by Type (2027-2032) & (Kg) Table 10. Global Anti-HMGB1 Antibody Sales Market Share in Volume by Type (2027-2032) Table 11. Global Anti-HMGB1 Antibody Sales by Type (2027-2032) & (US$ Million) Table 12. Global Anti-HMGB1 Antibody Sales Market Share in Value by Type (2027-2032) Table 13. Global Anti-HMGB1 Antibody Price by Type (2027-2032) & (US$/G) Table 14. North America Anti-HMGB1 Antibody Sales by Type (2021-2026) & (Kg) Table 15. North America Anti-HMGB1 Antibody Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Anti-HMGB1 Antibody Sales by Type (2021-2026) & (Kg) Table 17. Europe Anti-HMGB1 Antibody Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Anti-HMGB1 Antibody Sales by Type (2021-2026) & (Kg) Table 19. Asia-Pacific Anti-HMGB1 Antibody Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Anti-HMGB1 Antibody Sales by Type (2021-2026) & (Kg) Table 21. Latin America Anti-HMGB1 Antibody Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Anti-HMGB1 Antibody Sales by Type (2021-2026) & (Kg) Table 23. Middle East and Africa Anti-HMGB1 Antibody Sales by Type (2021-2026) & (US$ Million) Table 24. Anti-HMGB1 Antibody Industry Trends Table 25. Anti-HMGB1 Antibody Industry Drivers Table 26. Anti-HMGB1 Antibody Industry Opportunities and Challenges Table 27. Anti-HMGB1 Antibody Industry Restraints Table 28. Global Anti-HMGB1 Antibody Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Anti-HMGB1 Antibody Revenue Market Share by Company (2021-2026) Table 30. Global Anti-HMGB1 Antibody Sales by Company (2021-2026) & (Kg) Table 31. Global Anti-HMGB1 Antibody Sales Share by Company (2021-2026) Table 32. Global Anti-HMGB1 Antibody Market Price by Company (2021-2026) & (US$/G) Table 33. Global Anti-HMGB1 Antibody Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Anti-HMGB1 Antibody Major Company Production Sites and Headquarters Table 35. Global Anti-HMGB1 Antibody Company, Product Type & Application Table 36. Global Anti-HMGB1 Antibody Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Anti-HMGB1 Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Anti-HMGB1 Antibody Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Anti-HMGB1 Antibody Sales by Region (2021-2026) & (Kg) Table 41. Global Anti-HMGB1 Antibody Sales Market Share in Volume by Region (2021-2026) Table 42. Global Anti-HMGB1 Antibody Sales by Region (2021-2026) & (US$ Million) Table 43. Global Anti-HMGB1 Antibody Sales Market Share in Value by Region (2021-2026) Table 44. Global Anti-HMGB1 Antibody Sales (Kg), Value (US$ Million), Price (US$/G) and Gross Margin (2021-2026) Table 45. Global Anti-HMGB1 Antibody Sales by Region (2027-2032) & (Kg) Table 46. Global Anti-HMGB1 Antibody Sales Market Share in Volume by Region (2027-2032) Table 47. Global Anti-HMGB1 Antibody Sales by Region (2027-2032) & (US$ Million) Table 48. Global Anti-HMGB1 Antibody Sales Market Share in Value by Region (2027-2032) Table 49. Global Anti-HMGB1 Antibody Sales (Kg), Value (US$ Million), Price (US$/G) and Gross Margin (2027-2032) Table 50. Global Anti-HMGB1 Antibody Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Anti-HMGB1 Antibody Sales by Application (2021-2026) & (Kg) Table 52. Global Anti-HMGB1 Antibody Sales Market Share in Volume by Application (2021-2026) Table 53. Global Anti-HMGB1 Antibody Sales by Application (2021-2026) & (US$ Million) Table 54. Global Anti-HMGB1 Antibody Sales Market Share in Value by Application (2021-2026) Table 55. Global Anti-HMGB1 Antibody Price by Application (2021-2026) & (US$/G) Table 56. Global Anti-HMGB1 Antibody Sales by Application (2027-2032) & (Kg) Table 57. Global Anti-HMGB1 Antibody Sales Market Share in Volume by Application (2027-2032) Table 58. Global Anti-HMGB1 Antibody Sales by Application (2027-2032) & (US$ Million) Table 59. Global Anti-HMGB1 Antibody Sales Market Share in Value by Application (2027-2032) Table 60. Global Anti-HMGB1 Antibody Price by Application (2027-2032) & (US$/G) Table 61. North America Anti-HMGB1 Antibody Sales by Application (2021-2026) & (Kg) Table 62. North America Anti-HMGB1 Antibody Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Anti-HMGB1 Antibody Sales by Application (2021-2026) & (Kg) Table 64. Europe Anti-HMGB1 Antibody Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Anti-HMGB1 Antibody Sales by Application (2021-2026) & (Kg) Table 66. Asia-Pacific Anti-HMGB1 Antibody Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Anti-HMGB1 Antibody Sales by Application (2021-2026) & (Kg) Table 68. Latin America Anti-HMGB1 Antibody Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Anti-HMGB1 Antibody Sales by Application (2021-2026) & (Kg) Table 70. Middle East and Africa Anti-HMGB1 Antibody Sales by Application (2021-2026) & (US$ Million) Table 71. Abcam Company Information Table 72. Abcam Business Overview Table 73. Abcam Anti-HMGB1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/G) and Gross Margin (2021-2026) Table 74. Abcam Anti-HMGB1 Antibody Product Portfolio Table 75. Abcam Recent Development Table 76. Arigo Biolaboratories Company Information Table 77. Arigo Biolaboratories Business Overview Table 78. Arigo Biolaboratories Anti-HMGB1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/G) and Gross Margin (2021-2026) Table 79. Arigo Biolaboratories Anti-HMGB1 Antibody Product Portfolio Table 80. Arigo Biolaboratories Recent Development Table 81. Atlas Antibodies Company Information Table 82. Atlas Antibodies Business Overview Table 83. Atlas Antibodies Anti-HMGB1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/G) and Gross Margin (2021-2026) Table 84. Atlas Antibodies Anti-HMGB1 Antibody Product Portfolio Table 85. Atlas Antibodies Recent Development Table 86. BioLegend Company Information Table 87. BioLegend Business Overview Table 88. BioLegend Anti-HMGB1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/G) and Gross Margin (2021-2026) Table 89. BioLegend Anti-HMGB1 Antibody Product Portfolio Table 90. BioLegend Recent Development Table 91. BosterBio Company Information Table 92. BosterBio Business Overview Table 93. BosterBio Anti-HMGB1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/G) and Gross Margin (2021-2026) Table 94. BosterBio Anti-HMGB1 Antibody Product Portfolio Table 95. BosterBio Recent Development Table 96. Chondrex Company Information Table 97. Chondrex Business Overview Table 98. Chondrex Anti-HMGB1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/G) and Gross Margin (2021-2026) Table 99. Chondrex Anti-HMGB1 Antibody Product Portfolio Table 100. Chondrex Recent Development Table 101. Genetex Company Information Table 102. Genetex Business Overview Table 103. Genetex Anti-HMGB1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/G) and Gross Margin (2021-2026) Table 104. Genetex Anti-HMGB1 Antibody Product Portfolio Table 105. Genetex Recent Development Table 106. Leadgene Biomedical Company Information Table 107. Leadgene Biomedical Business Overview Table 108. Leadgene Biomedical Anti-HMGB1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/G) and Gross Margin (2021-2026) Table 109. Leadgene Biomedical Anti-HMGB1 Antibody Product Portfolio Table 110. Leadgene Biomedical Recent Development Table 111. Raybiotech Company Information Table 112. Raybiotech Business Overview Table 113. Raybiotech Anti-HMGB1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/G) and Gross Margin (2021-2026) Table 114. Raybiotech Anti-HMGB1 Antibody Product Portfolio Table 115. Raybiotech Recent Development Table 116. St John's Laboratory Company Information Table 117. St John's Laboratory Business Overview Table 118. St John's Laboratory Anti-HMGB1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/G) and Gross Margin (2021-2026) Table 119. St John's Laboratory Anti-HMGB1 Antibody Product Portfolio Table 120. St John's Laboratory Recent Development Table 121. Thermo Fisher Scientific Company Information Table 122. Thermo Fisher Scientific Business Overview Table 123. Thermo Fisher Scientific Anti-HMGB1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/G) and Gross Margin (2021-2026) Table 124. Thermo Fisher Scientific Anti-HMGB1 Antibody Product Portfolio Table 125. Thermo Fisher Scientific Recent Development Table 126. Merck Company Information Table 127. Merck Business Overview Table 128. Merck Anti-HMGB1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/G) and Gross Margin (2021-2026) Table 129. Merck Anti-HMGB1 Antibody Product Portfolio Table 130. Merck Recent Development Table 131. Sino Biological Company Information Table 132. Sino Biological Business Overview Table 133. Sino Biological Anti-HMGB1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/G) and Gross Margin (2021-2026) Table 134. Sino Biological Anti-HMGB1 Antibody Product Portfolio Table 135. Sino Biological Recent Development Table 136. North America Anti-HMGB1 Antibody Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 137. North America Anti-HMGB1 Antibody Sales by Country (2021-2026) & (Kg) Table 138. North America Anti-HMGB1 Antibody Sales Market Share by Country (2021-2026) Table 139. North America Anti-HMGB1 Antibody Sales Forecast by Country (2027-2032) & (Kg) Table 140. North America Anti-HMGB1 Antibody Sales Market Share Forecast by Country (2027-2032) Table 141. North America Anti-HMGB1 Antibody Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. North America Anti-HMGB1 Antibody Market Size by Country (2021-2026) & (US$ Million) Table 143. North America Anti-HMGB1 Antibody Market Share by Country (2021-2026) Table 144. North America Anti-HMGB1 Antibody Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. North America Anti-HMGB1 Antibody Market Share Forecast by Country (2027-2032) Table 146. Europe Anti-HMGB1 Antibody Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 147. Europe Anti-HMGB1 Antibody Sales by Country (2021-2026) & (Kg) Table 148. Europe Anti-HMGB1 Antibody Sales Market Share by Country (2021-2026) Table 149. Europe Anti-HMGB1 Antibody Sales Forecast by Country (2027-2032) & (Kg) Table 150. Europe Anti-HMGB1 Antibody Sales Market Share Forecast by Country (2027-2032) Table 151. Europe Anti-HMGB1 Antibody Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Europe Anti-HMGB1 Antibody Market Size by Country (2021-2026) & (US$ Million) Table 153. Europe Anti-HMGB1 Antibody Market Share by Country (2021-2026) Table 154. Europe Anti-HMGB1 Antibody Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Europe Anti-HMGB1 Antibody Market Share Forecast by Country (2027-2032) Table 156. Asia-Pacific Anti-HMGB1 Antibody Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 157. Asia-Pacific Anti-HMGB1 Antibody Sales by Country (2021-2026) & (Kg) Table 158. Asia-Pacific Anti-HMGB1 Antibody Sales Market Share by Country (2021-2026) Table 159. Asia-Pacific Anti-HMGB1 Antibody Sales Forecast by Country (2027-2032) & (Kg) Table 160. Asia-Pacific Anti-HMGB1 Antibody Sales Market Share Forecast by Country (2027-2032) Table 161. Asia-Pacific Anti-HMGB1 Antibody Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Asia-Pacific Anti-HMGB1 Antibody Market Size by Country (2021-2026) & (US$ Million) Table 163. Asia-Pacific Anti-HMGB1 Antibody Market Share by Country (2021-2026) Table 164. Asia-Pacific Anti-HMGB1 Antibody Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Asia-Pacific Anti-HMGB1 Antibody Market Share Forecast by Country (2027-2032) Table 166. Latin America Anti-HMGB1 Antibody Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 167. Latin America Anti-HMGB1 Antibody Sales by Country (2021-2026) & (Kg) Table 168. Latin America Anti-HMGB1 Antibody Sales Market Share by Country (2021-2026) Table 169. Latin America Anti-HMGB1 Antibody Sales Forecast by Country (2027-2032) & (Kg) Table 170. Latin America Anti-HMGB1 Antibody Sales Market Share Forecast by Country (2027-2032) Table 171. Latin America Anti-HMGB1 Antibody Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Latin America Anti-HMGB1 Antibody Market Size by Country (2021-2026) & (US$ Million) Table 173. Latin America Anti-HMGB1 Antibody Market Share by Country (2021-2026) Table 174. Latin America Anti-HMGB1 Antibody Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Latin America Anti-HMGB1 Antibody Market Share Forecast by Country (2027-2032) Table 176. Middle East and Africa Anti-HMGB1 Antibody Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 177. Middle East and Africa Anti-HMGB1 Antibody Sales by Country (2021-2026) & (Kg) Table 178. Middle East and Africa Anti-HMGB1 Antibody Sales Market Share by Country (2021-2026) Table 179. Middle East and Africa Anti-HMGB1 Antibody Sales Forecast by Country (2027-2032) & (Kg) Table 180. Middle East and Africa Anti-HMGB1 Antibody Sales Market Share Forecast by Country (2027-2032) Table 181. Middle East and Africa Anti-HMGB1 Antibody Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Middle East and Africa Anti-HMGB1 Antibody Market Size by Country (2021-2026) & (US$ Million) Table 183. Middle East and Africa Anti-HMGB1 Antibody Market Share by Country (2021-2026) Table 184. Middle East and Africa Anti-HMGB1 Antibody Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Middle East and Africa Anti-HMGB1 Antibody Market Share Forecast by Country (2027-2032) Table 186. Key Raw Materials Table 187. Raw Materials Key Suppliers Table 188. Anti-HMGB1 Antibody Distributors List Table 189. Anti-HMGB1 Antibody Customers List Table 190. Research Programs/Design for This Report Table 191. Authors List of This Report Table 192. Secondary Sources Table 193. Primary Sources List of Figures Figure 1. Anti-HMGB1 Antibody Image Figure 2. Global Anti-HMGB1 Antibody Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Anti-HMGB1 Antibody Market Size (2021-2032) & (US$ Million) Figure 4. Global Anti-HMGB1 Antibody Sales (2021-2032) & (Kg) Figure 5. Rabbit Anti-HMGB1 Antibody Image Figure 6. Global Rabbit Anti-HMGB1 Antibody Sales YoY Growth (2021-2032) & (Kg) Figure 7. Mouse Anti-HMGB1 Antibody Image Figure 8. Global Mouse Anti-HMGB1 Antibody Sales YoY Growth (2021-2032) & (Kg) Figure 9. Global Anti-HMGB1 Antibody Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Anti-HMGB1 Antibody Market Share by Type 2025 VS 2032 Figure 11. North America Anti-HMGB1 Antibody Sales Market Share in Volume by Type in 2025 Figure 12. North America Anti-HMGB1 Antibody Sales Market Share in Value by Type in 2025 Figure 13. Europe Anti-HMGB1 Antibody Sales Market Share in Volume by Type in 2025 Figure 14. Europe Anti-HMGB1 Antibody Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Anti-HMGB1 Antibody Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Anti-HMGB1 Antibody Sales Market Share in Value by Type in 2025 Figure 17. Latin America Anti-HMGB1 Antibody Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Anti-HMGB1 Antibody Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Anti-HMGB1 Antibody Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Anti-HMGB1 Antibody Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Anti-HMGB1 Antibody Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. ELISA Image Figure 24. Global ELISA Sales YoY Growth (2021-2032) & (Kg) Figure 25. Immunofluorescence Image Figure 26. Global Immunofluorescence Sales YoY Growth (2021-2032) & (Kg) Figure 27. Western Blot Image Figure 28. Global Western Blot Sales YoY Growth (2021-2032) & (Kg) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (Kg) Figure 31. Global Anti-HMGB1 Antibody Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Anti-HMGB1 Antibody Market Share by Application 2025 VS 2032 Figure 33. North America Anti-HMGB1 Antibody Sales Market Share in Volume by Application in 2025 Figure 34. North America Anti-HMGB1 Antibody Sales Market Share in Value by Application in 2025 Figure 35. Europe Anti-HMGB1 Antibody Sales Market Share in Volume by Application in 2025 Figure 36. Europe Anti-HMGB1 Antibody Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Anti-HMGB1 Antibody Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Anti-HMGB1 Antibody Sales Market Share in Value by Application in 2025 Figure 39. Latin America Anti-HMGB1 Antibody Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Anti-HMGB1 Antibody Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Anti-HMGB1 Antibody Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Anti-HMGB1 Antibody Sales Market Share in Value by Application in 2025 Figure 43. North America Anti-HMGB1 Antibody Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 44. North America Anti-HMGB1 Antibody Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Anti-HMGB1 Antibody Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Anti-HMGB1 Antibody Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Anti-HMGB1 Antibody Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 48. Europe Anti-HMGB1 Antibody Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Anti-HMGB1 Antibody Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Anti-HMGB1 Antibody Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Anti-HMGB1 Antibody Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 52. Asia-Pacific Anti-HMGB1 Antibody Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Anti-HMGB1 Antibody Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Anti-HMGB1 Antibody Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Anti-HMGB1 Antibody Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 56. Latin America Anti-HMGB1 Antibody Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Anti-HMGB1 Antibody Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Anti-HMGB1 Antibody Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Anti-HMGB1 Antibody Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 60. Middle East and Africa Anti-HMGB1 Antibody Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Anti-HMGB1 Antibody Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Anti-HMGB1 Antibody Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Anti-HMGB1 Antibody Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Anti-HMGB1 Antibody Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Rabbit Anti-HMGB1 Antibody
  • Mouse Anti-HMGB1 Antibody
Applications
  • ELISA
  • Immunofluorescence
  • Western Blot
  • Others
Companies covered
  • Abcam
  • Arigo Biolaboratories
  • Atlas Antibodies
  • BioLegend
  • BosterBio
  • Chondrex
  • Genetex
  • Leadgene Biomedical
  • Raybiotech
  • St John's Laboratory
  • Thermo Fisher Scientific
  • Merck
  • Sino Biological

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Anti-HMGB1 Antibody Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Anti-HMGB1 Antibody Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Anti-HMGB1 Antibody Market by Type
  6. 1.3.1 Rabbit Anti-HMGB1 Antibody
  7. 1.3.2 Mouse Anti-HMGB1 Antibody
  8. 1.4 Global Anti-HMGB1 Antibody Market Size by Type
  9. 1.4.1 Global Anti-HMGB1 Antibody Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Anti-HMGB1 Antibody Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Anti-HMGB1 Antibody Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Anti-HMGB1 Antibody Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Anti-HMGB1 Antibody Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Anti-HMGB1 Antibody Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Anti-HMGB1 Antibody Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Anti-HMGB1 Antibody Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Anti-HMGB1 Antibody Industry Trends
  2. 2.2 Anti-HMGB1 Antibody Industry Drivers
  3. 2.3 Anti-HMGB1 Antibody Industry Opportunities and Challenges
  4. 2.4 Anti-HMGB1 Antibody Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Anti-HMGB1 Antibody Revenue (2021-2026)
  2. 3.2 Global Top Players by Anti-HMGB1 Antibody Sales (2021-2026)
  3. 3.3 Global Top Players by Anti-HMGB1 Antibody Price (2021-2026)
  4. 3.4 Global Anti-HMGB1 Antibody Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Anti-HMGB1 Antibody Major Company Production Sites & Headquarters
  6. 3.6 Global Anti-HMGB1 Antibody Company, Product Type & Application
  7. 3.7 Global Anti-HMGB1 Antibody Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Anti-HMGB1 Antibody Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Anti-HMGB1 Antibody Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Anti-HMGB1 Antibody Tier 1, Tier 2, and Tier 3
4 Anti-HMGB1 Antibody Regional Status and Outlook
  1. 4.1 Global Anti-HMGB1 Antibody Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Anti-HMGB1 Antibody Historic Market Size by Region
  3. 4.2.1 Global Anti-HMGB1 Antibody Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Anti-HMGB1 Antibody Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Anti-HMGB1 Antibody Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Anti-HMGB1 Antibody Forecasted Market Size by Region
  7. 4.3.1 Global Anti-HMGB1 Antibody Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Anti-HMGB1 Antibody Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Anti-HMGB1 Antibody Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Anti-HMGB1 Antibody by Application
  1. 5.1 Anti-HMGB1 Antibody Market by Application
  2. 5.1.1 ELISA
  3. 5.1.2 Immunofluorescence
  4. 5.1.3 Western Blot
  5. 5.1.4 Others
  6. 5.2 Global Anti-HMGB1 Antibody Market Size by Application
  7. 5.2.1 Global Anti-HMGB1 Antibody Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Anti-HMGB1 Antibody Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Anti-HMGB1 Antibody Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Anti-HMGB1 Antibody Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Anti-HMGB1 Antibody Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Anti-HMGB1 Antibody Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Anti-HMGB1 Antibody Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Anti-HMGB1 Antibody Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Abcam
  2. 6.1.1 Abcam Company Information
  3. 6.1.2 Abcam Business Overview
  4. 6.1.3 Abcam Anti-HMGB1 Antibody Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Abcam Anti-HMGB1 Antibody Product Portfolio
  6. 6.1.5 Abcam Recent Developments
  7. 6.2 Arigo Biolaboratories
  8. 6.2.1 Arigo Biolaboratories Company Information
  9. 6.2.2 Arigo Biolaboratories Business Overview
  10. 6.2.3 Arigo Biolaboratories Anti-HMGB1 Antibody Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Arigo Biolaboratories Anti-HMGB1 Antibody Product Portfolio
  12. 6.2.5 Arigo Biolaboratories Recent Developments
  13. 6.3 Atlas Antibodies
  14. 6.3.1 Atlas Antibodies Company Information
  15. 6.3.2 Atlas Antibodies Business Overview
  16. 6.3.3 Atlas Antibodies Anti-HMGB1 Antibody Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Atlas Antibodies Anti-HMGB1 Antibody Product Portfolio
  18. 6.3.5 Atlas Antibodies Recent Developments
  19. 6.4 BioLegend
  20. 6.4.1 BioLegend Company Information
  21. 6.4.2 BioLegend Business Overview
  22. 6.4.3 BioLegend Anti-HMGB1 Antibody Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 BioLegend Anti-HMGB1 Antibody Product Portfolio
  24. 6.4.5 BioLegend Recent Developments
  25. 6.5 BosterBio
  26. 6.5.1 BosterBio Company Information
  27. 6.5.2 BosterBio Business Overview
  28. 6.5.3 BosterBio Anti-HMGB1 Antibody Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 BosterBio Anti-HMGB1 Antibody Product Portfolio
  30. 6.5.5 BosterBio Recent Developments
  31. 6.6 Chondrex
  32. 6.6.1 Chondrex Company Information
  33. 6.6.2 Chondrex Business Overview
  34. 6.6.3 Chondrex Anti-HMGB1 Antibody Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Chondrex Anti-HMGB1 Antibody Product Portfolio
  36. 6.6.5 Chondrex Recent Developments
  37. 6.7 Genetex
  38. 6.7.1 Genetex Company Information
  39. 6.7.2 Genetex Business Overview
  40. 6.7.3 Genetex Anti-HMGB1 Antibody Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Genetex Anti-HMGB1 Antibody Product Portfolio
  42. 6.7.5 Genetex Recent Developments
  43. 6.8 Leadgene Biomedical
  44. 6.8.1 Leadgene Biomedical Company Information
  45. 6.8.2 Leadgene Biomedical Business Overview
  46. 6.8.3 Leadgene Biomedical Anti-HMGB1 Antibody Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Leadgene Biomedical Anti-HMGB1 Antibody Product Portfolio
  48. 6.8.5 Leadgene Biomedical Recent Developments
  49. 6.9 Raybiotech
  50. 6.9.1 Raybiotech Company Information
  51. 6.9.2 Raybiotech Business Overview
  52. 6.9.3 Raybiotech Anti-HMGB1 Antibody Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Raybiotech Anti-HMGB1 Antibody Product Portfolio
  54. 6.9.5 Raybiotech Recent Developments
  55. 6.10 St John's Laboratory
  56. 6.10.1 St John's Laboratory Company Information
  57. 6.10.2 St John's Laboratory Business Overview
  58. 6.10.3 St John's Laboratory Anti-HMGB1 Antibody Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 St John's Laboratory Anti-HMGB1 Antibody Product Portfolio
  60. 6.10.5 St John's Laboratory Recent Developments
  61. 6.11 Thermo Fisher Scientific
  62. 6.11.1 Thermo Fisher Scientific Company Information
  63. 6.11.2 Thermo Fisher Scientific Business Overview
  64. 6.11.3 Thermo Fisher Scientific Anti-HMGB1 Antibody Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Thermo Fisher Scientific Anti-HMGB1 Antibody Product Portfolio
  66. 6.11.5 Thermo Fisher Scientific Recent Developments
  67. 6.12 Merck
  68. 6.12.1 Merck Company Information
  69. 6.12.2 Merck Business Overview
  70. 6.12.3 Merck Anti-HMGB1 Antibody Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Merck Anti-HMGB1 Antibody Product Portfolio
  72. 6.12.5 Merck Recent Developments
  73. 6.13 Sino Biological
  74. 6.13.1 Sino Biological Company Information
  75. 6.13.2 Sino Biological Business Overview
  76. 6.13.3 Sino Biological Anti-HMGB1 Antibody Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Sino Biological Anti-HMGB1 Antibody Product Portfolio
  78. 6.13.5 Sino Biological Recent Developments
7 North America by Country
  1. 7.1 North America Anti-HMGB1 Antibody Sales by Country
  2. 7.1.1 North America Anti-HMGB1 Antibody Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Anti-HMGB1 Antibody Sales by Country (2021-2026)
  4. 7.1.3 North America Anti-HMGB1 Antibody Sales Forecast by Country (2027-2032)
  5. 7.2 North America Anti-HMGB1 Antibody Market Size by Country
  6. 7.2.1 North America Anti-HMGB1 Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Anti-HMGB1 Antibody Market Size by Country (2021-2026)
  8. 7.2.3 North America Anti-HMGB1 Antibody Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Anti-HMGB1 Antibody Sales by Country
  2. 8.1.1 Europe Anti-HMGB1 Antibody Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Anti-HMGB1 Antibody Sales by Country (2021-2026)
  4. 8.1.3 Europe Anti-HMGB1 Antibody Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Anti-HMGB1 Antibody Market Size by Country
  6. 8.2.1 Europe Anti-HMGB1 Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Anti-HMGB1 Antibody Market Size by Country (2021-2026)
  8. 8.2.3 Europe Anti-HMGB1 Antibody Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Anti-HMGB1 Antibody Sales by Country
  2. 9.1.1 Asia-Pacific Anti-HMGB1 Antibody Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Anti-HMGB1 Antibody Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Anti-HMGB1 Antibody Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Anti-HMGB1 Antibody Market Size by Country
  6. 9.2.1 Asia-Pacific Anti-HMGB1 Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Anti-HMGB1 Antibody Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Anti-HMGB1 Antibody Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Anti-HMGB1 Antibody Sales by Country
  2. 10.1.1 South America Anti-HMGB1 Antibody Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Anti-HMGB1 Antibody Sales by Country (2021-2026)
  4. 10.1.3 South America Anti-HMGB1 Antibody Sales Forecast by Country (2027-2032)
  5. 10.2 South America Anti-HMGB1 Antibody Market Size by Country
  6. 10.2.1 South America Anti-HMGB1 Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Anti-HMGB1 Antibody Market Size by Country (2021-2026)
  8. 10.2.3 South America Anti-HMGB1 Antibody Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Anti-HMGB1 Antibody Sales by Country
  2. 11.1.1 Middle East and Africa Anti-HMGB1 Antibody Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Anti-HMGB1 Antibody Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Anti-HMGB1 Antibody Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Anti-HMGB1 Antibody Market Size by Country
  6. 11.2.1 Middle East and Africa Anti-HMGB1 Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Anti-HMGB1 Antibody Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Anti-HMGB1 Antibody Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Anti-HMGB1 Antibody Value Chain Analysis
  2. 12.1.1 Anti-HMGB1 Antibody Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Anti-HMGB1 Antibody Production Mode & Process
  7. 12.2 Anti-HMGB1 Antibody Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Anti-HMGB1 Antibody Distributors
  10. 12.2.3 Anti-HMGB1 Antibody Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst